Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
about
Extending the Frontiers Beyond Thermal Ablation by Radiofrequency Ablation: SBRT, Brachytherapy, SIRT (Radioembolization)Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsThermal ablation therapies in patients with breast cancer liver metastases: a review.Update on pancreatic neuroendocrine tumors.Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.Multimodal management of neuroendocrine liver metastases.Hepatocellular carcinoma: preclinical data on a dual-lumen catheter kit for fibrin sealant infusion following loco-regional treatments.The use of radiofrequency in cancer.Pancreatic Neuroendocrine Tumors: an Update.Metastatic insulinoma - prolonged survival after multimodal approachBiology and treatment of metastatic gastrointestinal neuroendocrine tumors.Emerging therapies and latest development in the treatment of unresectable pancreatic neuroendocrine tumors: an update for clinicians.Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?Techniques of interventional tumor therapy.Evaluation of two intraoperative gamma detectors for assessment of 177Lu activity concentration in vivo.Gastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-up.Liver-specific therapies for metastases of neuroendocrine pancreatic tumorsContemporary management of nonfunctioning pancreatic neuroendocrine tumors.Treatment options for unresectable neuroendocrine liver metastases.Clinical pathways for pancreatic neuroendocrine tumors.Image-guided percutaneous ablation therapies for local recurrences of thyroid tumors.Evolving treatment strategies for management of carcinoid tumors.Therapeutic strategies for neuroendocrine liver metastases.Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.Spinal cord compression after radiolabeled metaiodobenzylguanidine analogue therapy in advanced malignant insulinoma.Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma.Treatment of neuroendocrine tumor liver metastases.Carcinoid-syndrome: recent advances, current status and controversies.CT and enhanced CT in diagnosis of gastrointestinal neuroendocrine carcinomas.
P2860
Q26796524-1AAB4D08-6181-40F4-83C4-472BD9B6C82BQ28290833-66E52F80-0872-4277-8DA0-2F9E373AE98EQ34445101-5FF481B0-1CBE-4E29-9BD4-08FE2771C0BFQ34453043-663ADACE-FD90-4A6C-8E76-D14A67C74C7AQ34498450-0BCC01EC-8218-4488-88E2-AE4A08275EDEQ34528199-4E1A65B9-1C47-428E-8A16-D773BA149BAEQ35502388-4001CAB4-6FD7-41C3-BB24-42585B530415Q36116078-E35B4917-01D1-4DAA-9232-F5E4E75AB069Q36400062-DE30EFA2-D982-4303-A0FC-8EE134CCAC5FQ36516682-0D4E4648-D259-441B-BE1A-FA77A54DEC95Q37077832-7CE7F4BE-93B5-468B-AA24-093C87789B8FQ37255846-56D3462F-2359-4523-AFAC-B56CE8A43DDCQ37277977-A0511755-D6CD-44A8-8BE3-5784D5543B94Q37496689-D9B30C17-8752-46AC-BC14-F37769DD6F94Q37574732-47AACC84-241F-48EE-9031-E9870E407424Q37675588-13419C67-7F76-4A3E-8D8C-66B9B4FF1053Q37821300-8621D5D6-F706-4EE2-8FBE-F934496038D7Q37947138-FA5453C8-C6B8-4799-A7C4-F0162A312B4EQ38014498-05D71579-F674-483B-9F77-5771997A4568Q38015767-E94A71FE-94E0-436E-BBE7-0850815781FCQ38079941-B4235592-C126-420F-B567-35F80F2A4595Q38124702-0B8E14C2-A08E-47E1-86CE-093AE5F9B83FQ38255979-6537A113-6FD6-44F9-8623-87E2FA2BCCB6Q38262113-91A13761-8EEB-41D2-A3FF-E7D1BD9DC283Q38494154-95193CA2-FB6D-49EA-9091-18F2087CF9B2Q38956091-D23AA89B-82D9-4348-93C8-CF07C51EF8BAQ39773838-6FB9DDF3-98DD-41D1-BFDF-33744A68F85CQ41390489-235312A6-14BC-425E-A166-0EC8DA50201BQ42287138-FAA35A34-15E1-407A-95BF-2C449B24DA0AQ50094023-828C6672-B7E8-465E-B75F-54AF67961EE5Q50969115-389FB7A5-2593-4D18-9F20-5DB7042C63DE
P2860
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
@ast
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
@en
type
label
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
@ast
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
@en
prefLabel
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
@ast
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
@en
P2093
P1433
P1476
Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
@en
P2093
P304
P356
10.1007/S00261-004-0258-4
P577
2005-07-01T00:00:00Z